Primary peritoneal malignancies are a group of rare cancers involving the lining of the abdominal cavity. Cancers in this category include pseudomyxoma peritonei, cancer of the appendix, and cancer of the ovaries. Treatment of primary peritoneal malignancies is a highly specialized field and is carried out at only a few centers across the United States. The most effective treatment involves surgical debulking of the tumor followed by intraperitoneal hyperthermic chemoperfusion (HIPEC). Follow-up data show that patients who undergo this treatment live longer and have a better quality of life. The Division of Surgical Oncology at the University of Miami Miller School of Medicine was the first in South Florida to provide HIPEC as part of a comprehensive treatment program for primary peritoneal malignancies.
The Division of Surgical Oncology at the University of Miami Miller School of Medicine, was the first to perform the procedure, an intraperitoneal hyperthermic chemoperfusion (HIPEC) in South Florida. offering abdominal cancer patients a novel therapy that combines heat and chemotherapy. The procedure is administered during surgery and has extended the lives and improved the quality of life to patients with certain types of advanced abdominal cancer who might otherwise have limited treatment options.